L-asparaginase in the treatment of refractory and relapsed extranodal NK/T-cell lymphoma, nasal type.

MLA

Weiben Yong, et al. “L-Asparaginase in the Treatment of Refractory and Relapsed Extranodal NK/T-Cell Lymphoma, Nasal Type.” Annals of Hematology, vol. 88, no. 7, July 2009, pp. 647–52. EBSCOhost, https://doi.org/10.1007/s00277-008-0669-3.

APA

Weiben Yong, Wen Zheng, Jun Zhu, Yuntao Zhang, Xiaopei Wang, Yan Xie, Ningjing Lin, Bo Xu, Aiping Lu, Jiyou Li, Yong, W., Zheng, W., Zhu, J., Zhang, Y., Wang, X., Xie, Y., Lin, N., Xu, B., Lu, A., & Li, J. (2009). L-asparaginase in the treatment of refractory and relapsed extranodal NK/T-cell lymphoma, nasal type. Annals of Hematology, 88(7), 647–652. https://doi.org/10.1007/s00277-008-0669-3

Chicago

Weiben Yong, Wen Zheng, Jun Zhu, Yuntao Zhang, Xiaopei Wang, Yan Xie, Ningjing Lin, et al. 2009. “L-Asparaginase in the Treatment of Refractory and Relapsed Extranodal NK/T-Cell Lymphoma, Nasal Type.” Annals of Hematology 88 (7): 647–52. doi:10.1007/s00277-008-0669-3.